HCW Biologics Stock Quote HCWB - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.89

Bid

0.89

Ask

0.91

Volume

7,511,739

0.81 Day's Range 1.11

0.2721 52 Week Range 2.52

Market Cap

33.663M

Previous Close

1.10

Open

0.93

Last Trade

0.91

Last Trade Time

Financial Volume

$ 7,499,126

VWAP

0.998321

Average Volume (3m)

9,564,831

Shares Outstanding

37,823,394

Dividend Yield

PE Ratio

-1.44

Earnings Per Share (EPS)

-0.66

Revenue

2.84M

Net Profit

-24.99M

HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a signi... HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a significant contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.hcwbiologics.com

Headquarters

Wilmington, Delaware, USA

Founded

HCW Biologics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HCWB. The last closing price for HCW Biologics was $1.10. Over the last year, HCW Biologics shares have traded in a share price range of $ 0.2721 to $ 2.52.

HCW Biologics currently has 37,823,394 shares outstanding. The market capitalization of HCW Biologics is $41.61 million. HCW Biologics has a price to earnings ratio (PE ratio) of -1.44.

Form 8-K - Current report

Form 424B2 - Prospectus [Rule 424(b)(2)]

HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules

MIRAMAR, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.5836	190.46997389	0.3064	2.52	0.2721	112285549	1.22723319	CS
4	0.335	60.3603603604	0.555	2.52	0.2721	28157147	1.22456397	CS
12	0.4093	85.1466611192	0.4807	2.52	0.2721	9564831	1.2231573	CS
26	-0.26	-22.6086956522	1.15	2.52	0.2721	4452349	1.22226324	CS
52	-0.25	-21.9298245614	1.14	2.52	0.2721	2260613	1.22265781	CS
156	-2.05	-69.7278911565	2.94	3.32	0.2721	773782	1.25134171	CS
260	-6.61	-88.1333333333	7.5	7.51	0.2721	925802	2.10012511	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
FBRXForte Biosciences Inc	$ 13.60 (129.53%)	28.92M
QSIQuantum Si Inc	$ 1.39 (119.59%)	279.33M
XCURExicure Inc	$ 11.01 (89.18%)	22.91M
AGFYAgrify Corporation	$ 37.4635 (68.00%)	921.45k
SLXNSilexion Therapeutics Corporation	$ 0.3495 (54.51%)	198.66M
SKKSKK Holdings Limited	$ 4.55 (-47.28%)	816.93k
QMMMQMMM Holdings Limited	$ 0.713999 (-43.78%)	4.61M
XTKGX3 Holdings Company Ltd	$ 0.0901 (-37.82%)	5.95M
PRFXPainReform Ltd	$ 1.02 (-27.14%)	5.09M
GLEGlobal Engine Group Holding Ltd	$ 3.81 (-26.59%)	230.23k
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.191 (17.39%)	662.68M
DBGIDigital Brands Group Inc	$ 0.1345 (15.35%)	326.45M
NVDANVIDIA Corporation	$ 145.89 (-0.76%)	309.57M
QSIQuantum Si Inc	$ 1.39 (119.59%)	283.09M
SLXNSilexion Therapeutics Corporation	$ 0.3495 (54.51%)	200.06M